You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 81 No. 1, January 1960 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Papers Read Before the 79th Annual Meeting of the American Dermatological Association, Inc., Atlantic City, N. J., June 1, 1959 (Concluded)
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Acne, Estrogens and Spermatozoa

J. FRED MULLINS, M.D.; WRAY B. McCASH, M.D.; JULES K. LAMAR, Ph.D.

AMA Arch Derm. 1960;81(1):53-58.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has been demonstrated that estrogenic substances, given in sufficient amounts, will significantly decrease the amount of sebum produced by the sebaceous glands.1 A number of dermatologists have utilized female hormones to decrease the sebaceous activity and to aid in the therapy of cystic acne vulgaris.1-6 On several occasions, there have been references to a temporary or permanent decrease in spermatogenesis following the utilization of these substances and the question arises as to their safety.5-10

The purpose of this study was to give conjugated estrogenic substances (Premarin) to a group of normal men for a period of three months and to check carefully all components of the sperm count during this interval of time. Also, we checked for sideeffects from this estrogenic substance, as well as instituted placebos at the end of the three-month trial period. It was decided to carry all subjects on the true substance . . . [Full Text PDF of this Article]


Author Affiliations



Galveston, Texas

From the Department of Dermatology (J. Fred Mullins, Professor and Chairman), University of Texas Medical Branch.


Footnotes



Submitted for publication July 28, 1959.

Premarin was furnished by the Ayerst Laboratories, New York.

We are indebted to Dr. J. Allen Scott, Department of Preventive Medicine and Public Health for statistical analyses.

Read before the 79th Annual Meeting of The American Dermatological Association, Inc., Atlantic City, N.J., June 1, 1959.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.